There has been a great evolution in the development of coronary stents in order to avoid
both restenosis and thrombosis. Improvements have led to improvements in the design and …

Percutaneous coronary intervention (PCI) is a widely used therapy for coronary artery
disease (CAD), but it carries risks and complications. Adhering to evidence-based practice …

Background Optimal dual antiplatelet therapy (DAPT) duration in patients at high bleeding
risk (HBR) is not fully defined. We aimed to compare the safety and effectiveness of short …

In-stent restenosis concerning the coronary artery refers to the blood clotting-caused re-
narrowing of the blocked section of the artery, which is opened using a stent. The failure rate …

Background: The Academic Research Consortium for High Bleeding Risk (ARC-HBR)
criteria have been suggested as the standard definition of HBR. However, the prevalence of …

Background The optimal dual antiplatelet therapy (DAPT) duration and regimen in patients
undergoing percutaneous coronary intervention (PCI) using current generation drug eluting …

Deep learning (DL) application has demonstrated its enormous potential in accomplishing
biomedical tasks, such as vessel segmentation, brain visualization, and speech recognition …

Background This study aimed to report the 12‐month results of drug‐eluting stent (DES) for
the treatment of significant restenosis of the hemodialysis access. Materials and methods A …

Background Acute coronary syndromes (ACS) represent a context of higher thrombotic risk,
where larger advantages have been achieved by the administration of dual antiplatelet …

Background: Gastrointestinal bleeding (GIB) and intracranial bleeding (ICB) are frequently
observed as major bleeding events after percutaneous coronary intervention (PCI); …